High-purity therapeutic peptides, active pharmaceutical ingredients, and specialty chemicals manufactured under rigorous global quality standards.
Analyzing global supply chain shifts, regulatory paradigms, and technological breakthroughs driving modern Contract Development and Manufacturing Organizations (CDMOs).
The global pharmaceutical active pharmaceutical ingredient (API) and fine chemicals landscape is undergoing a structural transformation. Driven by rapid advancements in biotechnology, metabolic disease therapies, peptide therapeutics (such as GLP-1 receptor agonists like Semaglutide and Tirzepatide), and neuro-active molecular research, contract manufacturing facilities—specifically specialized OEM Calais Factory & Company operations—are now central to the global life sciences ecosystem.
Modern pharmaceutical brand owners and industrial chemical entities face unprecedented pressure: accelerating clinical-to-commercial timelines while navigating strict global regulatory standards including US FDA cGMP, EMA Annex 1 standards, ICH Q7 guidelines, and WHO compliance. In this environment, establishing high-capacity, technology-driven OEM chemical facilities is no longer just an operational alternative; it is a critical strategic imperative.
Providing robust, scalable, and fully compliant CDMO/OEM services across APIs, intermediate chemicals, and proprietary synthesis processes.
An overall factory construction footprint of 250,000 square meters constructed under international engineering standards. We provide ultra-flexible, scalable, and cost-effective batch and continuous manufacturing for fine chemicals, industrial plasticizers (such as Diethylene Glycol Dibenzoate), and noble metal catalyst solutions (Rhodium III Nitrate).
Gentolex delivers an extensive catalog of Active Pharmaceutical Ingredients (APIs) and specialty peptide intermediates for research and commercialization. Operates under strict cGMP environments supported by complete technical dossiers (DMF, COA, HPLC, MS) to ensure compliance worldwide.
Our multidisciplinary team of synthetic organic chemists and biochemical engineers specializes in route scouting, impurity profiling, crystallization optimization, and yield enhancement for complex multi-step peptide sequences and custom synthesis modules.
Designed for corporate partners seeking to avoid vendor fragmentation. We offer customized supply chain integration, raw material validation, cold-chain logistics management, and direct regulatory support across international trade corridors.
From Finished Dosage Form (FDF) licensing to analytical validation packages (ICH Q2), our legal and regulatory groups provide turn-key documentation suites, accelerating multi-national clinical approvals and registration dossiers.
Leveraging deep industrial experience, we advise institutions and biopharma firms on setup, analytical suite layout, cleanroom engineering (ISO 5 to ISO 8), and instrumentation qualification (IQ/OQ/PQ).
Supporting pharmaceutical innovation, cosmetics, industrial formulation, and nutritional science across more than 10 countries with direct regional operations.
Gentolex's mission centers on establishing secure commercial nodes connecting globally managed chemical capabilities with target local markets. With key international operational bases established in Mexico and South Africa, alongside established supply distribution channels across North America, Europe, and Asia-Pacific, our OEM operations accommodate region-specific requirements seamlessly.
Providing high-purity, low-endotoxin APIs such as Semaglutide, Tirzepatide, and Liraglutide for global research institutions and generic drug developers focusing on metabolic control, obesity, and type-2 diabetes formulations.
Manufacturing specialized pentadecapeptides and neuroactive research peptides, including BPC-157, TB-500, Selank, and Semax API, adhering to stringent purity controls (≥98% to 99.5% by HPLC).
Producing non-phthalate plasticizers like Diethylene Glycol Dibenzoate (CAS 120-55-8) and high-grade esters like Sebacic Acid Di-n-octyl Ester (CAS 2432-87-3) for international polymer, coating, and synthetic resin sectors.
Pioneering automated peptide synthesis, green continuous flow chemistry, and zero-emission OEM production cycles.
Implementation of machine-learning models to predict side-chain reactions and optimize amino acid coupling yields in solid-phase peptide synthesis (SPPS).
Transitioning key liquid-phase chemical processes to microfluidic continuous-flow reactors to enhance thermal efficiency, lower solvent consumption, and boost reaction kinetics.
Integration of closed-loop solvent recovery units across all 250,000 m² facilities, targeting an 85% reduction in volatile organic compound (VOC) emissions.
Deploying green hydrogen boilers, solar powered facility micro-grids, and fully audited net-zero chemical production processes across global OEM plants.
Creating seamless global bridges through reliable chemical services, stringent quality guarantees, and world-class contract manufacturing.
Gentolex’s overarching goal is to create long-term opportunities connecting the worldwide scientific and commercial sectors with better services and guaranteed chemical products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specifically establishing dedicated regional representatives in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
In-depth technical white papers detailing peptide active pharmaceutical ingredient synthesis, molecular mechanisms, and compliance methodologies.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research, Selank is a stable derivative of the endogenous tetrapeptide tuftsin, offering controlled molecular integrity for advanced laboratory and formulation studies.
Read Full Article
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 (Tβ4) peptide API solutions for biotechnology companies, pharmaceutical research organizations, and industrial formulation development. Our process features comprehensive LC-MS and HPLC batch verification.
Read Full Article
BPC-157 API is a synthetic pentadecapeptide that has gained widespread attention in biomedical peptide research due to its molecular properties related to tissue repair study models, gastrointestinal biological protection assays, and inflammatory response evaluation.
Read Full Article
With continuous advancements in neuroscience and life science research, neuroactive peptides have become a major strategic focal point. Semax, derived from an ACTH fragment, is synthesized under high-grade laboratory standards to ensure sequence precision and high lot-to-lot consistency.
Read Full Article
SS-31 API, also designated as Elamipretide, MTP-131, or Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to selectively bind cardiolipin in the inner mitochondrial membrane. It supports cellular bioenergetics research and organelle stabilization studies.
Read Full ArticleExpert answers regarding OEM chemical manufacturing, regulatory compliance, quality control, and global dispatch.
Explore our complete OEM product lineup for specialized biological synthesis, industrial formulations, and research applications.
